載入...

CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection

Maraviroc (MVC) is the first licensed antiretroviral therapeutic agent to target a host cell surface molecule, and successful HIV-1 entry blockade by this C-C chemokine receptor type 5 (CCR5)-antagonist potentiates immunomodulation. We hypothesized that MVC intensification impacts immunization respo...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Westrop, Samantha J, Moyle, Graeme, Jackson, Akil, Nelson, Mark, Mandalia, Sundhiya, Imami, Nesrina
格式: Artigo
語言:Inglês
出版: ScholarOne 2012
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510292/
https://ncbi.nlm.nih.gov/pubmed/22875102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00206
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!